Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Slidell, LA
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Slidell, LA
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Rockville, MD
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Buckley, MI
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Buckley, MI
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Hillsborough, NJ
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Hillsborough, NJ
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Lawrenceville, NJ
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Lawrenceville, NJ
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Toms River, NJ
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Toms River, NJ
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Greensboro, NC
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Greensboro, NC
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Whiteville, NC
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Whiteville, NC
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Kettering, OH
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Kettering, OH
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Wadsworth, OH
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Wadsworth, OH
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Pittsburgh, PA
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Kingsport, TN
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Kingsport, TN
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Austin, TX
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Dallas, TX
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Houston, TX
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Round Rock, TX
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Round Rock, TX
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
San Antonio, TX
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Tacoma, WA
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Martinsburg, WV
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Martinsburg, WV
Click here to add this to my saved trials
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated:  3/6/2018
Novo Nordisk Investigational Site
mi
from
Algiers,
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Status: Enrolling
Updated: 3/6/2018
Novo Nordisk Investigational Site
mi
from
Algiers,
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Southwestern American Indian Center
mi
from
Phoenix, AZ
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Southwestern American Indian Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Southern California
mi
from
Los Angeles, CA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Colorado Health Sciences Ctr.
mi
from
Aurora, CO
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Colorado Health Sciences Ctr.
mi
from
Aurora, CO
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Louisiana State University
mi
from
Baton Rouge, LA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Louisiana State University
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Johns Hopkins Pro-Health
mi
from
Baltimore, MD
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Johns Hopkins Pro-Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Diabetes Center
mi
from
Boston, MA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Joslin Diabetes Center
mi
from
Boston, MA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Northern Navajo Medical Center
mi
from
Shiprock, NM
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Northern Navajo Medical Center
mi
from
Shiprock, NM
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Columbia University
mi
from
New York, NY
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
The University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
The University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Miriam Hospital
mi
from
Providence, RI
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Tennessee, Memphis
mi
from
Memphis, TN
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Tennessee, Memphis
mi
from
Memphis, TN
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Baylor College of Medicine
mi
from
Houston, TX
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Texas Health Sciences Center
mi
from
San Antonio, TX
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Texas Health Sciences Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Univ of Washington
mi
from
Seattle, WA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Effect of Bariatric Surgery on Mechanisms of Type 2 Diabetes
Effect of Bariatric Surgery on Mechanisms of Type 2 Diabetes
Status: Enrolling
Updated:  3/7/2018
Cleveland Clinic Bariatric and Metabolic Institute, Department of Pathobiology
mi
from
Cleveland, OH
Effect of Bariatric Surgery on Mechanisms of Type 2 Diabetes
Effect of Bariatric Surgery on Mechanisms of Type 2 Diabetes
Status: Enrolling
Updated: 3/7/2018
Cleveland Clinic Bariatric and Metabolic Institute, Department of Pathobiology
mi
from
Cleveland, OH
Click here to add this to my saved trials
Smart Glucose Meter Project
Comparison of a Cellular-embedded Glucose Meter With Two-way Personalized Communication Between Patients and Care Managers With a Glucose Meter in Standard Practice in the Care of Diabetic Patients.
Status: Enrolling
Updated:  3/7/2018
University of Maryland
mi
from
Baltimore, MD
Smart Glucose Meter Project
Comparison of a Cellular-embedded Glucose Meter With Two-way Personalized Communication Between Patients and Care Managers With a Glucose Meter in Standard Practice in the Care of Diabetic Patients.
Status: Enrolling
Updated: 3/7/2018
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Montgomery, AL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Montgomery, AL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Burbank, CA
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Burbank, CA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Greenbrae, CA
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Greenbrae, CA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Clearwater, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Hollywood, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Jacksonville, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
New Port Richey, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
Ocala, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated:  3/7/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Belvidere, IL
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma
Status: Enrolling
Updated: 3/7/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Belvidere, IL
Click here to add this to my saved trials